Global Pleural Effusions Treatment Market To Generate A Revenue of USD 6.8 Billion By 2028

The global pleural effusions treatment market size was worth around USD 4.4 billion in 2021 and is predicted to grow to around USD 6.8 billion by 2028 with a compound annual growth rate (CAGR) of roughly 6.4% between 2022 and 2028.

Pleural effusion is the fluid buildup between the tissue layers that line the lungs and chest cavity. In order to lubricate the pleura surface, the body produces normal amounts of pleural fluid. The pleura surface is the thin tissue lining the chest cavity and surrounding the lungs. Pleural effusion occurs when the body produces abnormal or high amounts of this fluid. The two main types of pleural effusion are transudative pleural effusion & exudative effusion. When the blood pressure increases or the blood protein count lowers, transudative pleural effusion occurs due to fluid leakage in the pleural space. Exudative effusion is caused due to blockage of inflamed blood or lymph vessels.

The major risk factors in pleural effusions are smoking or drinking leading to lung, liver, or heart disease, and any asbestos contact. Generally, the medical condition does not have visible symptoms, but in some cases, may include signs like rapid breathing, hiccups, shortness of breath, cough, and chest pain. Pleural effusion treatment involves collecting a fluid sample on which a test can be performed. The test results could be indicative of protein levels, cancer cells, infection, fluid acidity, or cell counts. The end goal of these treatments is to either remove the fluid or prevent its building up along with determining the cause of the build-up and its treatment. Some related possible complications include pleural thickening, lung damage, pneumothorax after effusion drainage, and infection that may turn into an abscess.

The onset of Covid-19 was critical in global market growth since the problem is directly related to the lungs and chest, the two main body parts Covid-19 virus attacked. The healthcare sector was under tremendous pressure while dealing with patients who were Covid-19 infected along with infections related to pleural effusions.

The global pleural effusions treatment market is expected to grow owing to the rising number of heart failure, lung, breast, and kidney diseases across the globe. Since pleural effusions are a common side-effect of multiple other diseases, the global market growth trend is directly proportional to the rise in the number of other medical cases. As per a 2017 report submitted by European Cardiovascular Disease Statistics, over 3.9 million deaths related to cardiovascular diseases (CVD) are reported every year. In Europe, 45% of all deaths are related to CVD. The number is constantly rising owing to multiple factors like an increase in the geriatric population and unhealthy eating habits. The global market cap may also receive a positive push from the growing awareness of the disease. Since many healthcare professionals are now aware of the possible implications of the disease, there is a rising proactive trend of diagnosing the medical conditions before it worsens.

The discomfort associated with treatments related to pleural effusions may restrict the global market growth. However, the advancements in the understanding of the disease are expected to provide growth opportunities for global market expansion. Nonetheless, the lack of skilled professionals in emerging economies may challenge global market growth.

The global pleural effusion treatment market is segmented based on type, treatment, end-user, and region.

By type, exudative and transudative are the two global market segments where transudative type leads the segment. It occurs when the systemic factor causing absorption or formation of pleural fluid is altered. Almost 6% of the patients suffering from liver cirrhosis get diagnosed with pleural effusion that is associated with ascites, which is the leading source of transudative effusion.

Based on treatment, the global market segments are catheter, thoracentesis, pleuroperitoneal shunt, pleurodesis, and others. Thoracentesis treatment is used in case of large effusions whereas pleurodesis can prevent pleural effusions from coming back. In the USA, thoracentesis is performed more than 1.7 million times a year.

By end-user, the global market is segmented into ambulatory clinics, clinics, hospitals, and others. The global market is expected to be dominated by the hospital segment during the forecast period.

North America is expected to lead the global pleural effusions treatment market due to the rising number of medical cases in the region. In Mexico, pleural effusions are extremely common and affect 400 per 1 million of the population every year for which the most common causes are cancer, pneumonia, and heart failure. The regional growth may also be attributed to the rising innovations in the healthcare sector and patient-friendly treatment approach along with the presence of medical reimbursements. Asia-Pacific is also expected to grow significantly majorly due to the increasing population along with a stressful lifestyle.

The global pleural effusion treatment market is dominated by players like TruCorp, B. Braun Melsungen AG, Cook, Rocket Medical plc, Yushin Medical Co ltd, Boston Medical Products Inc. (Bess group company), Cardinal Health, Smiths Medical, and Armstrong Medical.

Recent Development:

• In April 2019, an update on the progress and encouraging results was posted by the University of California. The update was related to the study about tunneled pleural catheters related to refractory effusions caused by heart failure.
• In October 2021, an interactive panel discussion related to the management of malignant pleural effusions was held by healthcare professionals at Lyndon Baines Johnson Hospital. The discussion intended to explore every management strategy along with new combination techniques for management, and factors dictating the technique choice.

Browse the full “Global Pleural Effusions Treatment Market By Treatment (Catheter, Thoracentesis, Pleuroperitoneal Shunt, Pleurodesis, and Others), By Type (Exudative and Transudative), By End User (Ambulatory Clinics, Clinics, Hospitals, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/pleural-effusions-treatment-market

The global pleural effusions treatment market is segmented as follows:

By Treatment

• Catheter
• Thoracentesis
• Pleuroperitoneal Shunt
• Pleurodesis
• Others

By Type

• Exudative
• Transudative

By End User

• Ambulatory Clinics
• Clinics
• Hospitals
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com